Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

562
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
562
What is Photosynthesis?00:39

What is Photosynthesis?

111.1K
Photosynthesis is a multipart, biochemical process that occurs in plants as well as in some bacteria. It captures carbon dioxide and solar energy to produce glucose. Glucose stores chemical energy in the form of carbohydrates. The overall biochemical formula of photosynthesis is 6 CO2 + 6 H2O + Light energy → C6H12O6 + 6 O2. Photosynthesis releases oxygen into the atmosphere and is largely responsible for maintaining the Earth’s atmospheric oxygen content.
111.1K
Anatomy of Chloroplasts01:07

Anatomy of Chloroplasts

119.2K
Green algae and plants, including green stems and unripe fruit, harbor chloroplasts—the vital organelles where photosynthesis takes place. In plants, the highest density of chloroplasts is found in the mesophyll cells of leaves.
119.2K
Prokaryotic Transcriptional Activators and Repressors01:58

Prokaryotic Transcriptional Activators and Repressors

25.2K
The organization of prokaryotic genes in their genome is notably different from that of eukaryotes. Prokaryotic genes are organized, such that the genes for proteins involved in the same biochemical process or function are located together in groups. This group of genes, along with their regulatory elements, are collectively known as an operon. The functional genes in an operon are transcribed together to give a single strand of mRNA known as polycistronic mRNA.
Transcription of prokaryotic...
25.2K
Protein Networks02:26

Protein Networks

4.5K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K
Buffers02:56

Buffers

172.6K
A solution containing appreciable amounts of a weak conjugate acid-base pair is called a buffer solution, or a buffer. Buffer solutions resist a change in pH when small amounts of a strong acid or a strong base are added. A solution of acetic acid and sodium acetate is an example of a buffer that consists of a weak acid and its salt: CH3COOH (aq) + CH3COONa (aq). An example of a buffer that consists of a weak base and its salt is a solution of ammonia and ammonium chloride: NH3 (aq) + NH4Cl...
172.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the hypochromic erythrocyte and reticulocyte hemoglobin content provided by the Sysmex XE-5000 analyzer in diagnosis of iron deficiency erythropoiesis.

Clinical chemistry and laboratory medicine·2016
Same author

Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins.

Endocrine·2015
Same author

Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells.

Journal of cellular and molecular medicine·2015
Same author

Complete blood count at the ED: preanalytic variables for hemoglobin and leukocytes.

The American journal of emergency medicine·2015
Same author

Immunofluorescence vs immunochemiluminescent methods: AIA 2000 vs Immulite 2000.

Clinical biochemistry·2015
Same author

Considerations in parathyroid hormone testing.

Clinical chemistry and laboratory medicine·2015

Related Experiment Video

Updated: Jan 27, 2026

A Bedside, Single Burr Hole Approach to Multimodality Monitoring in Severe Brain Injury
06:18

A Bedside, Single Burr Hole Approach to Multimodality Monitoring in Severe Brain Injury

Published on: March 26, 2019

9.5K

New biochemical markers: from bench to bedside.

Martina Zaninotto1, Monica Maria Mion, Enrica Novello

  • 1Department of Laboratory Medicine, University-Hospital of Padova, Italy.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|April 3, 2007
PubMed
Summary

New biochemical markers can improve early risk assessment for acute coronary syndrome (ACS) beyond troponin levels. Developing and implementing these cardiac biomarkers requires collaboration for accurate clinical interpretation and patient stratification.

More Related Videos

Production and Isolation of Axons from Sensory Neurons for Biochemical Analysis Using Porous Filters
12:00

Production and Isolation of Axons from Sensory Neurons for Biochemical Analysis Using Porous Filters

Published on: July 8, 2014

14.6K
Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.4K

Related Experiment Videos

Last Updated: Jan 27, 2026

A Bedside, Single Burr Hole Approach to Multimodality Monitoring in Severe Brain Injury
06:18

A Bedside, Single Burr Hole Approach to Multimodality Monitoring in Severe Brain Injury

Published on: March 26, 2019

9.5K
Production and Isolation of Axons from Sensory Neurons for Biochemical Analysis Using Porous Filters
12:00

Production and Isolation of Axons from Sensory Neurons for Biochemical Analysis Using Porous Filters

Published on: July 8, 2014

14.6K
Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.4K

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Medical Diagnostics

Background:

  • Evaluating patients with chest pain for acute coronary syndrome (ACS) is challenging, time-consuming, and costly.
  • While troponins detect cardiac injury, normal values do not exclude cardiac event risk.
  • Advances in understanding atherosclerosis and molecular disease progression enable new biochemical marker development.

Purpose of the Study:

  • To explore the potential of novel biochemical markers for earlier and more accurate cardiovascular risk assessment.
  • To identify biomarkers reflecting inflammation and plaque instability for improved prognosis and risk stratification.
  • To outline the requirements for effective clinical implementation of new cardiovascular biomarkers.

Main Methods:

  • Review of recent investigations into the pathobiology of atherosclerosis and cardiovascular disease.
  • Identification of selected biomarkers released during cardiovascular disease development.
  • Focus on markers indicating inflammatory processes and plaque instability.
  • Consideration of marker requirements: biological plausibility, cost-effective assays, and clinical interpretation.

Main Results:

  • Emerging biomarkers offer insights into inflammatory processes and plaque instability.
  • These markers can aid in prognosis and risk stratification for cardiovascular disease.
  • Successful implementation requires high-quality, rapid assays and optimal clinical cut-offs.

Conclusions:

  • Translating new biomarker discoveries requires robust analytical characterization and routine assay development.
  • Effective use necessitates standardized performance assessment, clear interpretative reporting, and physician training.
  • Coordinated efforts among clinicians, technologists, statisticians, and industry are crucial for optimizing biomarker value.